The Complete Requirements Checklist to Get Blenrep (Belantamab Mafodotin) Covered by UnitedHealthcare in North Carolina
Answer Box: Blenrep Coverage Status
Blenrep (belantamab mafodotin) has been withdrawn from the U.S. market by GSK. UnitedHealthcare will deny coverage requests for commercial Blenrep because it's no longer commercially available. However, patients may access Blenrep through GSK's compassionate use program if already enrolled in